BMCS UPDATE WOODLAND HILLS, CA / ACCESSWIRE /

Quote:

---

WOODLAND HILLS, CA / ACCESSWIRE / June 26, 2023 / BioTech Medics, Inc. BMCS
is pleased to announce that the firm has made significant steps to diversify BMCS into a new dynamic and productive business. Management is transitioning back to its vast history and roots in the biotech sector.

According to Anthony K. Miller, CEO, "BMCS has finally elevated from the Expert Market to an OTC Markets Yield status and ultimately to a Current status. Over the past two years we focused most of our efforts as a digital asset business and as a result faced significant opposition in the regulatory environment, as a result of this the management has decided to shift its assets and energy back the origins of the firm, the biotech sector as our path. Management has also abandoned its name change to BMCS Sumcoin Index Fund, retaining our current name. Note BMCS still maintains significant digital assets and management is currently in negotiations to utilize those assets to enhance our new vision.

Our new business model going forward will be in the calcium, calcium carbonate and silica marketplaces. In the coming weeks we will provide investors with information regarding our new ventures; management feels this path is very exciting and beneficial for sustained growth. We really think our opportunities are tremendous in this sector. Next week we will launch our new website @ www.biotechmedics.co that will be informative of this new vision and following this launch we will discuss and announce (with press) deals we currently have in place and the assets we are acquiring. Coming soon we will also announce visions we have with our related companies and how they will fit within this new direction.

About BioTech Medics, Inc.: BioTech Medics, Inc is a publicly traded Wyoming company traded on the OTC Markets under the stock symbol BMCS located in Los Angeles California. BioTech Medics Inc. is and has historically been a biotech firm that still has significant digital assets.

---